These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2843084)

  • 1. Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.
    Woolf NK; Ochi JW; Silva EJ; Sharp PA; Harris JP; Richman DD
    Antimicrob Agents Chemother; 1988 Jun; 32(6):865-72. PubMed ID: 2843084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing loss in experimental cytomegalovirus infection of the guinea pig inner ear: prevention by systemic immunity.
    Woolf NK; Harris JP; Ryan AF; Butler DM; Richman DD
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):350-6. PubMed ID: 2992353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic and electrophysiological response to cytomegaloviral inner ear infection in the guinea pig.
    Harris JP; Woolf NK; Ryan AF; Butler DM; Richman DD
    J Infect Dis; 1984 Oct; 150(4):523-30. PubMed ID: 6092483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
    Fong CK; Cohen SD; McCormick S; Hsiung GD
    Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclophosphamide on the pathogenesis of cytomegalovirus-induced labyrinthitis.
    Darmstadt GL; Keithley EM; Harris JP
    Ann Otol Rhinol Laryngol; 1990 Dec; 99(12):960-8. PubMed ID: 2173893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vestibular changes after guinea pig cytomegalovirus infection.
    Young YH; Nomura Y
    Acta Otolaryngol Suppl; 1995; 520 Pt 1():157-9. PubMed ID: 8749107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effect of oxetanocin G against guinea pig cytomegalovirus infection in vitro and in vivo.
    Yamamoto N; Yamada Y; Daikoku T; Nishiyama Y; Tsutsui Y; Shimada N; Takahashi K
    J Antibiot (Tokyo); 1990 Dec; 43(12):1573-8. PubMed ID: 2177463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental herpes simplex virus and cytomegalovirus labyrinthitis.
    Nomura Y; Hara M; Kurata T
    Acta Otolaryngol Suppl; 1989; 457():57-66. PubMed ID: 2538996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital cytomegalovirus labyrinthitis and sensorineural hearing loss in guinea pigs.
    Woolf NK; Koehrn FJ; Harris JP; Richman DD
    J Infect Dis; 1989 Dec; 160(6):929-37. PubMed ID: 2555420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral infection and the inner ear.
    Nomura Y; Harada T; Hara M
    ORL J Otorhinolaryngol Relat Spec; 1988; 50(4):201-11. PubMed ID: 2845327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of morphological and physiological changes in the cochlea induced by cytomegalovirus.
    Keithley EM; Woolf NK; Harris JP
    Laryngoscope; 1989 Apr; 99(4):409-14. PubMed ID: 2538687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.
    Freitas VR; Smee DF; Chernow M; Boehme R; Matthews TR
    Antimicrob Agents Chemother; 1985 Aug; 28(2):240-5. PubMed ID: 3010840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)] guanine. A new antiviral agent against Cytomegalovirus].
    Petersen CS; Skinhøj P
    Ugeskr Laeger; 1989 Aug; 151(34):2156-8. PubMed ID: 2773153
    [No Abstract]   [Full Text] [Related]  

  • 14. Guinea pig model of transplacental congenital cytomegaloviral infection with analysis for labyrinthitis.
    Strauss M; Griffith BP
    Am J Otol; 1991 Mar; 12(2):97-100. PubMed ID: 1647141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late sequelae of cochlear infection.
    Keithley EM; Harris JP
    Laryngoscope; 1996 Mar; 106(3 Pt 1):341-5. PubMed ID: 8614201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of idiopathic sudden sensorineural hearing loss: antiviral treatment of experimental herpes simplex virus infection of the inner ear.
    Stokroos RJ; Albers FW; Schirm J
    Ann Otol Rhinol Laryngol; 1999 May; 108(5):423-8. PubMed ID: 10335700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model.
    Katano H; Sato Y; Tsutsui Y; Sata T; Maeda A; Nozawa N; Inoue N; Nomura Y; Kurata T
    Microbes Infect; 2007 Feb; 9(2):183-91. PubMed ID: 17208485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.
    Duke AE; Smee DF; Chernow M; Boehme R; Matthews TR
    Antiviral Res; 1986 Aug; 6(5):299-308. PubMed ID: 3021055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental cytomegalovirus infection: viremic spread to the inner ear.
    Fukuda S; Keithley EM; Harris JP
    Am J Otolaryngol; 1988; 9(3):135-41. PubMed ID: 2845828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.